What does elevated procalcitonin (PCT) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated procalcitonin (PCT) levels typically indicate a bacterial infection, particularly a severe systemic infection like sepsis, with levels above 0.5 ng/mL suggesting possible bacterial infection, and levels exceeding 2.0 ng/mL strongly indicating sepsis or severe bacterial infection. Procalcitonin is a protein that increases dramatically during bacterial infections but remains relatively low during viral infections or non-infectious inflammatory conditions 1. Normal procalcitonin levels are below 0.1 ng/mL.

Key Points to Consider

  • Procalcitonin is particularly useful for guiding antibiotic therapy decisions, as rising levels may indicate the need to start antibiotics, while falling levels suggest effective treatment or that antibiotics might be safely discontinued 1.
  • The test is valuable because it can help distinguish between bacterial and viral infections, potentially reducing unnecessary antibiotic use.
  • However, procalcitonin should always be interpreted alongside clinical symptoms, other laboratory findings, and the patient's overall condition, as certain non-infectious conditions like trauma, surgery, or certain cancers can also cause elevated levels 1.
  • Recent studies have shown that PCT may be elevated during severe viral illness, including influenza and COVID-19, potentially making its discriminating power for predicting the causative microorganisms less useful 1.

Clinical Application

  • In ICU patients with suspected sepsis, clinicians should not initially withhold antibiotics, but PCT levels of less than 0.5 µg/L or levels that decrease by greater than or equal to 80% from peak levels may guide antibiotic discontinuation once patients stabilize 1.
  • PCT-guided antibiotic treatment in ICU patients with infection and sepsis patients has been shown to result in improved survival and lower antibiotic treatment duration 1.
  • Measuring PCT in critically ill patients with a new fever and no clear focus of infection with low to intermediate clinical probability of bacterial infection is recommended in addition to bedside clinical evaluation, but not in patients with high clinical probability of bacterial infection 1.

From the Research

Elevated Procalcitonin (PCT) Indications

Elevated procalcitonin (PCT) levels are associated with several clinical conditions, including:

  • Bacterial infections, particularly sepsis 2, 3, 4, 5, 6
  • Inflammatory responses to bacterial toxins and cytokines 3
  • Renal involvement in pediatric urinary tract infections 2
  • Secondary inflammations 2
  • Non-bacterial diseases such as malaria, severe trauma, burns, and medullary carcinoma of the thyroid 5

Procalcitonin as a Diagnostic Marker

PCT is considered a promising diagnostic marker for sepsis and antibiotic therapy due to its:

  • Rapid elevation in response to bacterial infections 2, 5
  • Correlation with the severity of illness 2
  • Ability to differentiate between bacterial and viral infections, although not always effective 2, 4
  • Utility in monitoring response to antimicrobial therapy 2, 3, 4

Clinical Applications of Procalcitonin

PCT has several clinical applications, including:

  • Guiding antimicrobial therapy in special patient populations, such as those with renal dysfunction, cardiac compromise, or immunocompromised states 3
  • Diagnosing bacterial infections and guiding antibiotic treatment in patients with respiratory illness 4
  • Monitoring the resolution of infection and guiding decisions regarding early termination of antibiotic treatment 4
  • Predicting outcomes in patients with sepsis, although the optimal cut-offs for starting or discontinuing antibiotic treatment are uncertain 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Procalcitonin in special patient populations: Guidance for antimicrobial therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020

Research

[Procalcitonin - importance for the diagnosis of bacterial infections].

Therapeutische Umschau. Revue therapeutique, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.